The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.

Lee HJ, Seok J, Kang S, Oh S, Hwang JW, Kim YJ, Seo J, Hoe HS

Open source

DOI
10.1186/s12974-026-03855-7
Published
2026 May 20
Container
Journal of neuroinflammation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12974-026-03855-7,
  title = {The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.},
  author = {Lee HJ and Seok J and Kang S and Oh S and Hwang JW and Kim YJ and Seo J and Hoe HS},
  year = {2026},
  journal = {Journal of neuroinflammation},
  doi = {10.1186/s12974-026-03855-7},
  url = {https://doi.org/10.1186/s12974-026-03855-7}
}

RIS

TY  - JOUR
TI  - The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.
AU  - Lee HJ
AU  - Seok J
AU  - Kang S
AU  - Oh S
AU  - Hwang JW
AU  - Kim YJ
AU  - Seo J
AU  - Hoe HS
PY  - 2026
JO  - Journal of neuroinflammation
DO  - 10.1186/s12974-026-03855-7
UR  - https://doi.org/10.1186/s12974-026-03855-7
ER  - 

APA

HJ, L., J, S., S, K., S, O., JW, H., YJ, K., J, S., & HS, H. (2026). The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.. Journal of neuroinflammation. https://doi.org/10.1186/s12974-026-03855-7

Source records